SARS-CoV-2 / COVID-19 Antibody Research Solutions

s

s

HuCAL® Recombinant Monoclonal Antibody Generation Service

Request or Download a Copy ▸

s

s

Bio-Rad's products are used in research and clinical laboratories around the world, contributing to advancement of COVID-19 research, SARS-CoV-2 screening assays, and vaccine development. We are committed to providing reliable, sensitive solutions to help you combat this global pandemic.

This page specifically lists our antibody related product offerings. If you have a specific question about coronavirus solutions, please contact your local sales office or representative.

As we adhere to shelter in place guidelines worldwide, Bio-Rad continues to process orders and offer customer service and technical support.

Antibody Solutions for Coronavirus Research

Bio-Rad Antibodies provide complete solutions for all your antibody needs, with a large catalog of highly cited antibodies, and the ability to provide custom monoclonal generation in just 8 weeks.

Antibodies for Immune Cell Characterization in COVID-19 Infection

Antibodies to profile immune response to COVID-19 infection and monitor virus-induced inflammation. Choose from thousands of antibodies against targets including:

• Innate immune response to viral infection: pattern recognition receptors and toll-like receptors
   

• Targeted adaptive immune response against the virus: T cell and B cell markers
   

• Inflammatory response: cytokines and chemokines
   

Antibodies to Immunoglobulins

To determine the development of an immune response against the SARS-CoV-2 virus, the detection of IgG, IgM, and IgA antibodies appears to be a sensitive approach. Bio-Rad offers a wide selection of anti-human IgA, IgG, and IgM antibodies for research use only in a variety of formats including full length antibodies, Fab fragments, purified, cross-adsorbed, and serum.
 

Rapid Custom Antibody Generation with HuCAL® Technology

Get highly specialized antibodies for coronavirus research, diagnostic testing, plus vaccine and therapeutic development:

• Fab antibodies against your target antigens in as little as 8 weeks
• Conversion to fully human IgG and IgM serological control antibodies
• Anti-idiotypic antibodies against your biologic drug for bioanalytical assays
   

Anti-Tocilizumab Antibodies

Antibodies for bioanalytical method development to measure tocilizumab and biosimilar products. Ready-made recombinant monoclonal anti-idiotypic antibodies, highly specific for the humanized antibody drug tocilizumab (Actemra/RoActemra).
 

Studying Coronavirus in Animal Species?

Discover our industry leading portfolio of species-specific antibodies for immune response research and coronavirus antibody range.

Find out more

Get Ahead while Working from Home 

The current period we are all living through provides moments of stillness in which we can reset and think about the work we are doing. Bio-Rad can support you with different resources to enable you to make the most out of this time and hone your skills.

We have compiled some useful educational resources to extend your knowledge of antibodies and how to use them effectively, ready for when you go back to the lab.

Read the fascinating new blogs: “Keeping Distance from the Lab: 9 Ways to Be Productive” and “Diary of a Coronavirologist” from the front line during the 2020 SARS-CoV2 (COVID-19) pandemic.

Keeping Distance from the Lab: 9 Ways to Be Productive
Includes recommendations on how to effectively use your time while working away from the lab

More Blogs
Containing tips and tricks to help you when you get back in the lab 

Secondary Antibodies - Learn it Your Way
Explains step-by-step what you need to know about secondary antibodies, what you need to do, and how to do it

Articles and Mini-reviews
Our range of technical reviews provide a deep understanding of specific topics related to areas as diverse as immunology, drug monitoring assays, or veterinary research

Podcasts: Spin Break
Keep your mind active with our short podcasts

Webinars
Take a look at our range of webinars and videos to learn in more depth about a wide range of topics

Diary of a Coronavirologist

Stuart Weston, a post-doctoral researcher at the University of Maryland School of Medicine, USA, who is working on coronaviruses and influenza, shares his insights on what it is like to be a coronavirologist during the 2020 SARS-CoV2 (COVID-19) pandemic in this guest blog.